Identification of the P2Y12 receptor in nucleotide inhibition of exocytosis from bovine chromaffin cells

Molecular Pharmacology

Volumn 66, Issue 3, 2004, Pages 601-611

  Ennion, Steven J ^a   Powell, Andrew D ^b   Seward, Elizabeth P ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE DIPHOSPHATE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ARC 69931MX; CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; N 6 (2 METHYLTHIOETHYL) 2 (3,3,3 TRIFLUOROPROPYLTHIO) BETA,GAMMA DICHLOROMETHYLENE ADENOSINE TRIPHOSPHATE; NUCLEOTIDE; PURINE P2Y RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y13 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CATTLE; CELL CLONE; CHROMAFFIN CELL; CONTROLLED STUDY; ELECTRIC CAPACITANCE; EXOCYTOSIS; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR3.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR3.4; MEMBRANE CONDUCTANCE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CATTLE; CHROMAFFIN CELLS; CLONING, MOLECULAR; ELECTROPHYSIOLOGY; EXOCYTOSIS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; OOCYTES; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; URIDINE TRIPHOSPHATE; XENOPUS LAEVIS;

EID: 4944262878     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.000224     Document Type: Article

References (40)

1. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24:52-55.
2. Abe M, Endoh T, and Suzuki T (2003) Extracellular ATP-induced calcium channel inhibition mediated by P1/P2Y purinoceptors in hamster submandibular ganglion neurons. Br J Pharmacol 138:1535-1543.
3. 12 receptor. Mol Pharmacol 64:1210-1216.
4. Boehm S and Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43-99.
5. Boyer JL, Zohn IE, Jacobson KA, and Harden TK (1994) Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors. Br J Pharmacol 113:614-620.
6. 6 receptors. J Biol Chem 276:11939-11948.
7. 2+ channel modulation in bovine chromaffin cells. Neuron 20:1255-1268.
8. 4 receptors: characterization of a suramin and PPADS-insensitive response to UTP. Br J Pharmacol 119:1301-1303.
9. 2+ entry in bovine adrenal chromaffin cells: different patterns induced by histamine and angiotensin II and relationship to catecholamine release. J Cell Sci 105:913-921.
10. i. J Biol Chem 276:41479-41485.
11. Cunha RA and Ribeiro JA (2000) ATP as a presynaptic modulator. Life Sci 68:119-137.
12. 2+ channel currents in cultured bovine adrenal chromaffin cells. Neuron 16:1027-1036.
13. Diverse-Pierluissi M, Dunlap K, and Westhead EW (1991) Multiple actions of extracellular ATP on calcium currents in cultured bovine chromaffin cells. Proc Natl Acad Sci USA 88:1261-1265.
14. Dolphin AC (2003) G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55:607-627.
15. Erb L, Garrad R, Wang Y, Quinn T, Turner JT, and Weisman GA (1995) Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem 270:4185-4188.
16. Fidler N and Fernandez JM (1989) Phase tracking: an improved phase detection technique for cell membrane capacitance measurements. Biophys J 56:1153-1162.
17. 4 receptor to neuronal ion channels. Br J Pharmacol 138:400-406.
18. + currents in rat sympathetic neurones. Br J Pharmacol 126:1009-1017.
19. Forsyth KM, Bjur RA, and Westfall DP (1991) Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J Pharmacol Exp Ther 256:821-826.
20. Gandia L, Garcia AG, and Morad M (1993) ATP modulation of calcium channels in chromaffin cells. J Physiol 470:55-72.
21. Harvey RJ and Darlison MG (1991) Random-primed cDNA synthesis facilitates the isolation of multiple 5′-cDNA ends by RACE. Nucleic Acids Res 19:4002.
22. Henderson DJ, Elliot DG, Smith GM, Webb TE, and Dainty IA (1995) Cloning and characterisation of a bovine P2Y receptor. Biochem Biophys Res Commun 212:648-656.
23. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond) 409:202-207.
24. 15, for AMP and adenosine. J Biol Chem 279:19790-19799.
25. Ingall AH, Dixon J, Bailey A, Coombs ME, Cox D, McInally JI, Hunt SF, Kindon ND, Teobald BJ, Willis PA, et al. (1999) Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem 42:213-220.
26. 2+ channels by antithrombotic drugs. Br J Pharmacol 138:343-350.
27. Kulick MB and von Kügelgen I (2002) P2Y-receptors mediating an inhibition of the evoked entry of calcium through N-type calcium channels at neuronal processes. J Pharmacol Exp Ther 303:520-526.
28. 13 receptor. Mol Pharmacol 64:104-112.
29. Moskvina E, Unterberger U, and Boehm S (2003) Activity-dependent autocrine-paracrine activation of neuronal P2Y receptors. J Neurosci 23:7479-7488.
30. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067.
31. Powell AD, Teschemacher AG, and Seward EP (2000) P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels. J Neurosci 20:606-616.
32. Sak K and Webb TE (2002) A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch Biochem Biophys 397:131-136.
33. 12 nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277:31390-31400.
34. 1 receptor. Mol Pharmacol 60:432-439.
35. Teschemacher AG and Seward EP (2000) Bidirectional modulation of exocytosis by angiontensin II involves multiple G-protein-regulated transduction pathways in adrenal chromaffin cells. J Neurosci 20:4776-4785.
36. Unterberger U, Moskvina E, Scholze T, Freissmuth M, and Boehm S (2002) Inhibition of adenylyl cyclase by neuronal P2Y receptors. Br J Pharmacol 135:673-684.
37. 2+ currents in PC12 cells. Eur J Neurosci 13:899-908.
38. Von Kügelgen I, Schoffel E, and Starke K (1989) Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 340:522-532.
39. 13 receptor-type. Br J Pharmacol 141:141-151.
40. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang Z I, Wu CP, Poo MM, and Duan S (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40:971-982.